Details

Autor(en) / Beteiligte

• KAJSTURA, Jan
• FIORDALISO, Fabio
• ANDREOLI, Anna Maria
• BAOSHENG LI
• CHIMENTI, Stefano
• MEDOW, Marvin S
• LIMANA, Federica
• NADAL-GINARD, Bernardo
• LERI, Annarosa
• ANVERSA, Piero

Titel

IGF-1 Overexpression Inhibits the Development of Diabetic Cardiomyopathy and Angiotensin II–Mediated Oxidative Stress

Ist Teil von

• Diabetes (New York, N.Y.), 2001-06, Vol.50 (6), p.1414-1424

Ort / Verlag

Alexandria, VA: American Diabetes Association

Erscheinungsjahr

2001

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• IGF-1 Overexpression Inhibits the Development of Diabetic Cardiomyopathy and Angiotensin II–Mediated Oxidative Stress Jan Kajstura 1 , Fabio Fiordaliso 1 3 , Anna Maria Andreoli 1 , Baosheng Li 1 , Stefano Chimenti 1 , Marvin S. Medow 2 , Federica Limana 1 , Bernardo Nadal-Ginard 1 , Annarosa Leri 1 and Piero Anversa 1 1 Medicine and 2 Pediatrics, New York Medical College, Valhalla, New York 3 Istituto Di Ricerche Farmacologiche Mario Negri, Milan, Italy Abstract Stimulation of the local renin-angiotensin system and apoptosis characterize the diabetic heart. Because IGF-1 reduces angiotensin (Ang) II and apoptosis, we tested whether streptozotocin-induced diabetic cardiomyopathy was attenuated in IGF-1 transgenic mice (TGM). Diabetes progressively depressed ventricular performance in wild-type mice (WTM) but had no hemodynamic effect on TGM. Myocyte apoptosis measured at 7 and 30 days after the onset of diabetes was twofold higher in WTM than in TGM. Myocyte necrosis was apparent only at 30 days and was more severe in WTM. Diabetic nontransgenic mice lost 24% of their ventricular myocytes and showed a 28% myocyte hypertrophy; both phenomena were prevented by IGF-1. In diabetic WTM, p53 was increased in myocytes, and this activation of p53 was characterized by upregulation of Bax, angiotensinogen, Ang type 1 (AT 1 ) receptors, and Ang II. IGF-1 overexpression decreased these biochemical responses. In vivo accumulation of the reactive O 2 product nitrotyrosine and the in vitro formation of H 2 O 2 -˙OH in myocytes were higher in diabetic WTM than TGM. Apoptosis in vitro was detected in myocytes exhibiting high H 2 O 2 -˙OH fluorescence, and apoptosis in vivo was linked to the presence of nitrotyrosine. H 2 O 2 -˙OH generation and myocyte apoptosis in vitro were inhibited by the AT 1 blocker losartan and the O 2 scavenger Tiron. In conclusion, IGF-1 interferes with the development of diabetic myopathy by attenuating p53 function and Ang II production and thus AT 1 activation. This latter event might be responsible for the decrease in oxidative stress and myocyte death by IGF-1. Footnotes Address correspondence and reprint requests to Jan Kajstura, Department of Medicine, New York Medical College, Vosburgh Pavilion, Room 302A, Valhalla, New York. E-mail: jan_kajstura{at}nymc.edu . Received for publication 27 October 2000 and accepted in revised form 15 March 2001. Ang, angiotensin; Aogen, angiotensinogen; AT 1 , Ang receptor type 1; CM-H 2 DCFDA, 5-(6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate; LVEDP, left ventricular end-diastolic pressure; LVSP, left ventricular systolic pressure; OD, optical density; PI, propidium iodide; RAS, renin-Ang system; ROS, reactive oxygen species; STZ, streptozotocin; TdT, terminal deoxynucleotidyl transferase; TGM, transgenic mice; WTM, wild-type mice.